Frank Tverdek

1.1k total citations
53 papers, 765 citations indexed

About

Frank Tverdek is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Frank Tverdek has authored 53 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 23 papers in Epidemiology and 22 papers in Oncology. Recurrent topics in Frank Tverdek's work include Antifungal resistance and susceptibility (17 papers), Neutropenia and Cancer Infections (16 papers) and Antibiotic Resistance in Bacteria (10 papers). Frank Tverdek is often cited by papers focused on Antifungal resistance and susceptibility (17 papers), Neutropenia and Cancer Infections (16 papers) and Antibiotic Resistance in Bacteria (10 papers). Frank Tverdek collaborates with scholars based in United States, South Korea and Australia. Frank Tverdek's co-authors include Dimitrios P. Kontoyiannis, Samuel L Aitken, Dong Sik Jung, Diamantis P. Kofteridis, Roy F. Chemaly, Kenneth V. I. Rolston, Sang Taek Heo, Bruno Granwehr, Jeffrey J. Bruno and Ryan K. Shields and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Frank Tverdek

47 papers receiving 752 citations

Peers

Frank Tverdek

EPIDE

PHARM

ONCOL

Alessio Mesini Italy

Shellee A. Grim United States

Oryan Henig Israel

Rupali Jain United States

Diamantis P. Kofteridis Greece

Gregory Eschenauer United States

Renato Pascale Italy

Linda Bussini Italy

Michele Wible United States

Carlos Fernández-Mazarrasa Spain

Alessio Mesini Italy

Frank Tverdek

339 ×0.8

280 ×0.8

EPIDE

101 ×0.6

147 ×0.8

PHARM

90 ×0.6

ONCOL

Citations per year, relative to Frank Tverdek Frank Tverdek (= 1×) peers Alessio Mesini

Countries citing papers authored by Frank Tverdek

Since Specialization

Citations

This map shows the geographic impact of Frank Tverdek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Tverdek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Tverdek more than expected).

Fields of papers citing papers by Frank Tverdek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Tverdek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Tverdek. The network helps show where Frank Tverdek may publish in the future.

Co-authorship network of co-authors of Frank Tverdek

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Tverdek. A scholar is included among the top collaborators of Frank Tverdek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Tverdek. Frank Tverdek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lindsay, Julian, Elizabeth M. Krantz, Frank Tverdek, et al.. (2025). P-1750. Assessment of Antimicrobial Stewardship Guided CYP2C19 Pharmacogenomic Voriconazole Dosing: Practicalities and Impact on Clinical Management. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Davis, Matthew R, et al.. (2025). You’ve Got a Friend in Me: Curbside Questions Infectious Diseases Clinicians Ask Infectious Diseases Pharmacists. Clinical Infectious Diseases. 82(1). 58–61.

Liu, Catherine, Emily A. Rosen, Hannah Imlay, et al.. (2025). Tackling antimicrobial resistance in people who are immunocompromised: leveraging diagnostic and antimicrobial stewardship. The Lancet Infectious Diseases. 26(1). e30–e48. 1 indexed citations

Rosen, Emily A., Elizabeth M. Krantz, Denise J. McCulloch, et al.. (2024). COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics. Transplantation and Cellular Therapy. 30(11). 1108.e1–1108.e11. 2 indexed citations

Tverdek, Frank, Samuel L Aitken, Victor E. Mulanovich, et al.. (2024). Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center. Open Forum Infectious Diseases. 11(5). ofae235–ofae235. 1 indexed citations

Krantz, Elizabeth M., Frank Tverdek, Emily A. Rosen, et al.. (2024). Epidemiology and Outcomes of Recurrent C Difficile Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study. Open Forum Infectious Diseases. 11(10). ofae570–ofae570.

Ueda, Masumi, et al.. (2023). Analysis of health care facility-onset Clostridioides difficile infection (CDI) in a hematopoietic cell transplant (HCT) unit: A call for diagnostic stewardship in a complex patient population. American Journal of Infection Control. 52(3). 374–376. 2 indexed citations

Tverdek, Frank, et al.. (2023). Antimicrobials in patients with hematologic malignancies and recipients of hematopoietic cell transplantation and other cellular therapies. Transplant Infectious Disease. 25(S1). e14129–e14129.

Krantz, Elizabeth M., Jessica Morris, Frank Tverdek, et al.. (2023). Antiviral Prescribing Among Patients at an Ambulatory Cancer Center With Laboratory-Confirmed Influenza. Open Forum Infectious Diseases. 10(5). ofad254–ofad254. 1 indexed citations

10.

Lindsay, Julian, Elizabeth M. Krantz, Jessica Morris, et al.. (2022). Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center. Transplantation and Cellular Therapy. 28(8). 511.e1–511.e10. 10 indexed citations

11.

Tverdek, Frank, Sang Taek Heo, Samuel L Aitken, Bruno Granwehr, & Dimitrios P. Kontoyiannis. (2017). Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses. Antimicrobial Agents and Chemotherapy. 61(8). 70 indexed citations

12.

Heo, Sang Taek, Samuel L Aitken, Frank Tverdek, & Dimitrios P. Kontoyiannis. (2017). How common is subsequent central nervous system toxicity in asymptomatic patients with haematologic malignancy and supratherapeutic voriconazole serum levels?. Clinical Microbiology and Infection. 23(6). 387–390. 10 indexed citations

13.

Chisholm, Gary B., et al.. (2017). Timing to antibiotic therapy in septic oncologic patients presenting without hypotension. Supportive Care in Cancer. 25(11). 3357–3363. 15 indexed citations

14.

Phe, Kady, et al.. (2016). Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study: Table 1.. Journal of Antimicrobial Chemotherapy. 71(12). 3585–3587. 13 indexed citations

15.

Tverdek, Frank, Diamantis P. Kofteridis, & Dimitrios P. Kontoyiannis. (2016). Antifungal agents and liver toxicity: a complex interaction. Expert Review of Anti-infective Therapy. 14(8). 765–776. 78 indexed citations

16.

Aitken, Samuel L, Jeffrey J. Tarrand, Lalitagauri M. Deshpande, et al.. (2016). High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production inEnterobacteriaceaeBloodstream Infections at a Major Cancer Center: Table 1.. Clinical Infectious Diseases. 63(7). 954–958. 55 indexed citations

17.

DiPippo, Adam J., Frank Tverdek, Jeffrey J. Tarrand, et al.. (2016). Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure. Journal of Infection. 74(3). 243–247. 25 indexed citations

18.

Aitken, Samuel L, Dimitrios P. Kontoyiannis, Micah M. Bhatti, et al.. (2016). Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient. The Pediatric Infectious Disease Journal. 35(9). 1040–1042. 34 indexed citations

19.

Nesher, Lior, et al.. (2015). Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center. Infection. 43(5). 545–550. 3 indexed citations

20.

Tverdek, Frank, et al.. (2014). First-dose pharmacokinetics of aminoglycosides in critically ill haematological malignancy patients. International Journal of Antimicrobial Agents. 45(1). 46–53. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact